Patent · US Active

Methods for stratifying and annotating cancer drug treatment options

US8583380B2 · kind B2 · utility

34Cited by
20References
81Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2009
Grant dateNov 12, 2013
Priority date
Expiry dateSep 4, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.